| 000 | 01487 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515023259.0 | ||
| 264 | 0 | _c20061017 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/01.ftd.0000195617.69721.a5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilms, E B | |
| 245 | 0 | 0 |
_aPharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cApr 2006 |
||
| 300 |
_a219-25 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xblood |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aAzithromycin _xblood |
| 650 | 0 | 4 |
_aCystic Fibrosis _xcomplications |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeutrophils _xmetabolism |
| 650 | 0 | 4 |
_aPseudomonas Infections _xcomplications |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aSputum _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTouw, D J | |
| 700 | 1 | _aHeijerman, H G M | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 28 _gno. 2 _gp. 219-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ftd.0000195617.69721.a5 _zAvailable from publisher's website |
| 999 |
_c16232258 _d16232258 |
||